Administration of EpCAM-CAR-T cells in CRC xenograft inhibited tumor growth and increased cytotoxic cytokines tumor necrosis factor-α (TNF-α) and IFN-γ [281]. This evidence concerns the gene TNF and colorectal carcinoma.